论文部分内容阅读
目的探讨甘舒霖30R在治疗2型糖尿病患者中的应用和疗效。方法选取我院门诊部于2010年1月~2013年10月应用甘舒霖30R治疗的初诊2型糖尿病患者30例(观察组),另选取同一时期我院应用诺和灵30R治疗的2型糖尿病患者30例(对照组),对两组患者的治疗效果进行比较。结果两组患者治疗后的FBG、2h BG指标均明显下降(P<0.05),且两组间比较无明显差异(P>0.05),两组血糖达标时间比较无明显差异(P>0.05);两组不良反应发生率比较无明显差异P>0.05。结论甘舒霖30R在2型糖尿病患者的治疗中安全、有效。
Objective To investigate the application and efficacy of Ganshulin 30R in the treatment of type 2 diabetes. Methods 30 cases of newly diagnosed type 2 diabetic patients treated with Gansuolin 30R from January 2010 to October 2013 in our hospital were selected, and another type 2 diabetic patients treated with norreben 30R in our hospital during the same period were selected. 30 cases (control group), the treatment effect of two groups of patients were compared. Results After treatment, FBG and 2h BG index of both groups were significantly decreased (P <0.05), and there was no significant difference between the two groups (P> 0.05). There was no significant difference between the two groups in the time of reaching blood glucose level (P> 0.05). No significant difference in the incidence of adverse reactions between the two groups P> 0.05. Conclusion Ganshu Lin 30R is safe and effective in the treatment of type 2 diabetes mellitus.